0001209191-16-110591.txt : 20160325
0001209191-16-110591.hdr.sgml : 20160325
20160325152013
ACCESSION NUMBER: 0001209191-16-110591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160323
FILED AS OF DATE: 20160325
DATE AS OF CHANGE: 20160325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161529602
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-23
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-03-23
4
M
0
5130
35.35
A
270414
D
Common Stock
2016-03-23
4
S
0
3030
80.64
D
267384
D
Common Stock
2016-03-23
4
S
0
900
81.48
D
266484
D
Common Stock
2016-03-23
4
S
0
800
82.77
D
265684
D
Common Stock
2016-03-23
4
S
0
200
83.33
D
265484
D
Common Stock
2016-03-23
4
S
0
200
84.54
D
265284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (Right to Buy)
35.35
2016-03-23
4
M
0
5130
0.00
D
2016-07-19
Common Stock
5130
76960
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $80.64 (range $80.15 to $81.12).
Open market sales reported on this line occurred at a weighted average price of $81.48 (range $81.22 to $82.02).
Open market sales reported on this line occurred at a weighted average price of $82.77 (range $82.28 to $83.25).
Open market sales reported on this line occurred at a weighted average price of $83.33 (range $83.29 to $83.37).
Open market sales reported on this line occurred at a weighted average price of $84.54 (range $84.53 to $84.54).
Fully vested.
Omar White, Attorney-In-Fact
2016-03-25